Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Liabilities from Discontinued Operations (2014 - 2022)

Danaher (DHR) posted Liabilities from Discontinued Operations of $1.1 billion for Q4 2022, up 86.28% on a QoQ basis from $605.0 million in Q4 2018.

Analysis

Danaher (DHR) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends

Danaher has reported Liabilities from Discontinued Operations for 4 years, with the latest figure at $1.1 billion in Q4 2022.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $1.1 billion in Q4 2022; TTM through Dec 2022 was $1.1 billion, a N/A change from a year earlier, with the FY2022 full-year figure at $1.1 billion, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was $1.1 billion for Q4 2022 at Danaher, up from $605.0 million in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was $1.1 billion in Q4 2022, with the low at $605.0 million in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.13 Bn
Dec 31, 2018 605.00 Mn
Dec 31, 2015 1.84 Bn
Oct 2, 2015 42.40 Mn
Dec 31, 2014 467.60 Mn